(310) 312-8095 Menu

Blog

PRP Platelet Rich Plasma Receives Conditional Approval from Medicare for Wound Healing Indication

Soft tissue wounds from conditions like Diabetes cause tremendous challenges to our healthcare system. Billions of dollars are spent on therapies that are currently not ideal resulting in disability & mortality. The decision reverses nearly 20 years for non-coverage for platelet rich plasma (PRP) treatments.

CMS the governing body for Medicare covered procedures granted coverage to AutoloGel via a Co Cytomedix under its Coverage with Evidence Development (CED) program.

The Co must establish positive research to continue receiving coverage. However this landmark decision opens the door for increased awareness about Orthobiologics, which will likely represent the future in orthopedics.  The wound model that has 3 phases including:  inflammation, proliferation and remodeling/repair phase mimics the process for soft tissue healing in tendon & cartilage. Hopefully convincing data will continue to emerge surrounding PRP use in wounds to drive other indications to the forefront like knee Osteoarthritis that is increasing at an alarming rate.


Back to blog

OHC Coronavirus (COVID-19) Update View Update Virtual Consultation Schedule Now!

OHC Coronavirus (COVID-19) Update:

The health, safety and well being of our patients in the community is our highest priority.

We will be offering virtual consults and follow up visits from the comfort of your home to access our physicians during this uncertain time.

Please contact (310) 312-8095 for more details.

For the latest updates on COVID-19 and prevention please follow the CDC Recommendations